Skip to content

Study of medicinal properties of a plant Lepidagathis keralensis

â??Phyto - pharmacological evaluation of Lepidagathis keralensis Madhus. & N.P.Singh . â?? An extrta- pharmacopoeial drug in folklore practiceâ??

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044445
Enrollment
30
Registered
2022-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N898- Other specified noninflammatory disorders of vagina

Interventions

None listed

Sponsors

Dr Radhika C
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Vulvovaginal candidiasis

Exclusion criteria

Exclusion criteria: Diabetes mellitus, under Immunosupressants, Pregnancy, Those taking Systemic antibiotics, known cases of HIV and other STDs

Design outcomes

Primary

MeasureTime frame
Reduction in vaginal Itching, White discharge,redness, burning sensationTimepoint: Before treatment, After 10days treatment and After 7days follow up

Secondary

MeasureTime frame
Microbiological cure, culture for candida alicansTimepoint: 10 days

Countries

India

Contacts

Public ContactDr Radhika C

Parul Institute of Ayurveda

rekha.parmar@paruluniversity.ac.in9724306523

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026